- Our services
- Synthetic VHH Library
- Our technologies
- Our references
New-York, NY, USA - 14 November
Antibody-Drug conjugates or ADCs combine the unique targeting properties of monoclonal antibodies with the potent cell killing ability of cytotoxic drugs. Unlike traditional chemotherapeutic agents, ACDs allow a sensitive targeting of cancer cells while avoiding healthy cells and represent a promising lead for cancer treatments.
On November 14th, the New York Academy of Sciences organizes a symposium in New-York, entitled "Antibody-Drug Conjugates: Oncology and Beyond", to discuss the challenges and last discoveries around this innovative therapeutic approach.
Dr. Petra Tafelmeyer, Director of Scientific Project USA, will attend this event and will be happy to discuss with you how your project can benefit from our services. Feel free to contact us now to arrange a meeting with her.
Tweet Add to Calendar 11-14-2017 00:00:00 11-14-2017 00:00:00 35 NYAS-Antibody-Drug Conjugates: Oncology and Beyond Meet Petra in NY for a NYAS meeting around ADCs New-York, NY, USA NYAS true MM/DD/YYYY
Online Event - 09 November
Dr. Jean-Christophe Rain, Director of Technology Development & Barbara Ruggiero, Director of Business Development, will give a 30 minutes long webinar entitled:
"In vitro selection & validation of synthetic single-domain antibodies & applications"
Join us on November 9th at 4:00 pm (Paris time).
Why should you attend?
> Discover why Hybribody VHHs are so reliable and innovative.
> Learn more about our unique phage display antibody selection process.
> Find out how Hybribody is a versatile tool that can be used in many ways: ELISA, PLA, IF...
> Ask your questions to our experts directly in the chat.
Tweet Add to Calendar 11-092017 16:00:00 11-09-2017 16:30:00 40 Join us for our Hybribody webinar We will give a presentation on November 9th at 4:00 pm (Paris time) to present Hybribody Online Event Hybrigenics Services false MM/DD/YYYY